UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:TFAP2A-MAK |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: TFAP2A-MAK | FusionPDB ID: 90258 | FusionGDB2.0 ID: 90258 | Hgene | Tgene | Gene symbol | TFAP2A | MAK | Gene ID | 7020 | 57538 |
Gene name | transcription factor AP-2 alpha | alpha kinase 3 | |
Synonyms | AP-2|AP-2alpha|AP2TF|BOFS|TFAP2 | CMH27|MAK|MIDORI | |
Cytomap | 6p24.3 | 15q25.3 | |
Type of gene | protein-coding | protein-coding | |
Description | transcription factor AP-2-alphaAP-2 transcription factoractivating enhancer-binding protein 2-alphaactivator protein 2transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | alpha-protein kinase 3muscle alpha-kinasemuscle alpha-protein kinasemyocyte induction differentiation originator | |
Modification date | 20200328 | 20200313 | |
UniProtAcc | . | Q9BXY0 | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000319516, ENST00000379604, ENST00000379608, ENST00000379613, ENST00000482890, ENST00000497266, | ENST00000538030, ENST00000536370, ENST00000313243, ENST00000354489, ENST00000474039, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 4 X 4 X 3=48 | 4 X 4 X 4=64 |
# samples | 4 | 4 | |
** MAII score | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/64*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: TFAP2A [Title/Abstract] AND MAK [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | TFAP2A(10404741)-MAK(10764839), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a transcription factor due to the frame-shifted ORF. TFAP2A-MAK seems lost the major protein functional domain in Hgene partner, which is a tumor suppressor due to the frame-shifted ORF. TFAP2A-MAK seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. TFAP2A-MAK seems lost the major protein functional domain in Tgene partner, which is a kinase due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TFAP2A | GO:0000122 | negative regulation of transcription by RNA polymerase II | 8321221|9520389|20066163 |
Hgene | TFAP2A | GO:0008285 | negative regulation of cell proliferation | 20607706 |
Hgene | TFAP2A | GO:0030501 | positive regulation of bone mineralization | 19578371 |
Hgene | TFAP2A | GO:0043066 | negative regulation of apoptotic process | 20066163 |
Hgene | TFAP2A | GO:0043525 | positive regulation of neuron apoptotic process | 20607706 |
Hgene | TFAP2A | GO:0045595 | regulation of cell differentiation | 20607706 |
Hgene | TFAP2A | GO:0045892 | negative regulation of transcription, DNA-templated | 20607706 |
Hgene | TFAP2A | GO:0045893 | positive regulation of transcription, DNA-templated | 12586840 |
Hgene | TFAP2A | GO:0045944 | positive regulation of transcription by RNA polymerase II | 7555706|7559606|11278550|20808827 |
Hgene | TFAP2A | GO:0070172 | positive regulation of tooth mineralization | 19578371 |
Hgene | TFAP2A | GO:0071281 | cellular response to iron ion | 20808827 |
Hgene | TFAP2A | GO:2000378 | negative regulation of reactive oxygen species metabolic process | 20066163 |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-AN-A0AR-01A | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000379613 | TFAP2A | chr6 | 10404741 | - | ENST00000313243 | MAK | chr6 | 10764839 | - | 2911 | 1027 | 98 | 1081 | 327 |
ENST00000379613 | TFAP2A | chr6 | 10404741 | - | ENST00000474039 | MAK | chr6 | 10764839 | - | 2911 | 1027 | 98 | 1081 | 327 |
ENST00000379604 | TFAP2A | chr6 | 10404741 | - | ENST00000313243 | MAK | chr6 | 10764839 | - | 2900 | 1016 | 87 | 1070 | 327 |
ENST00000379604 | TFAP2A | chr6 | 10404741 | - | ENST00000474039 | MAK | chr6 | 10764839 | - | 2900 | 1016 | 87 | 1070 | 327 |
ENST00000319516 | TFAP2A | chr6 | 10404741 | - | ENST00000313243 | MAK | chr6 | 10764839 | - | 2824 | 940 | 101 | 994 | 297 |
ENST00000319516 | TFAP2A | chr6 | 10404741 | - | ENST00000474039 | MAK | chr6 | 10764839 | - | 2824 | 940 | 101 | 994 | 297 |
ENST00000379608 | TFAP2A | chr6 | 10404741 | - | ENST00000313243 | MAK | chr6 | 10764839 | - | 3408 | 1524 | 778 | 1578 | 266 |
ENST00000379608 | TFAP2A | chr6 | 10404741 | - | ENST00000474039 | MAK | chr6 | 10764839 | - | 3408 | 1524 | 778 | 1578 | 266 |
ENST00000482890 | TFAP2A | chr6 | 10404741 | - | ENST00000313243 | MAK | chr6 | 10764839 | - | 3001 | 1117 | 242 | 1171 | 309 |
ENST00000482890 | TFAP2A | chr6 | 10404741 | - | ENST00000474039 | MAK | chr6 | 10764839 | - | 3001 | 1117 | 242 | 1171 | 309 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000379613 | ENST00000313243 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.009177532 | 0.99082243 |
ENST00000379613 | ENST00000474039 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.009177532 | 0.99082243 |
ENST00000379604 | ENST00000313243 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.00911806 | 0.9908819 |
ENST00000379604 | ENST00000474039 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.00911806 | 0.9908819 |
ENST00000319516 | ENST00000313243 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.01921344 | 0.9807866 |
ENST00000319516 | ENST00000474039 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.01921344 | 0.9807866 |
ENST00000379608 | ENST00000313243 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.023554634 | 0.9764454 |
ENST00000379608 | ENST00000474039 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.023554634 | 0.9764454 |
ENST00000482890 | ENST00000313243 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.005349606 | 0.9946504 |
ENST00000482890 | ENST00000474039 | TFAP2A | chr6 | 10404741 | - | MAK | chr6 | 10764839 | - | 0.005349606 | 0.9946504 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >90258_90258_1_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000319516_MAK_chr6_10764839_ENST00000313243_length(amino acids)=297AA_BP=279 MPKRFQGAGPTEPSSPCPAGTSRQERRAAMSILAKMGDWQDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADFQPPYFPPPYQPI YPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIHSLPHA IEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLN -------------------------------------------------------------- >90258_90258_2_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000319516_MAK_chr6_10764839_ENST00000474039_length(amino acids)=297AA_BP=279 MPKRFQGAGPTEPSSPCPAGTSRQERRAAMSILAKMGDWQDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADFQPPYFPPPYQPI YPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIHSLPHA IEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAEVQRRLSPPECLN -------------------------------------------------------------- >90258_90258_3_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379604_MAK_chr6_10764839_ENST00000313243_length(amino acids)=327AA_BP=309 MPSSSPSSFSSSTSSPSSSSSCAHRRQPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVG QSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRR DYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVP -------------------------------------------------------------- >90258_90258_4_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379604_MAK_chr6_10764839_ENST00000474039_length(amino acids)=327AA_BP=309 MPSSSPSSFSSSTSSPSSSSSCAHRRQPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVG QSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRR DYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVP -------------------------------------------------------------- >90258_90258_5_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379608_MAK_chr6_10764839_ENST00000313243_length(amino acids)=266AA_BP=248 MLVHSFSAMDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGW PGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSN -------------------------------------------------------------- >90258_90258_6_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379608_MAK_chr6_10764839_ENST00000474039_length(amino acids)=266AA_BP=248 MLVHSFSAMDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGW PGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSN -------------------------------------------------------------- >90258_90258_7_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379613_MAK_chr6_10764839_ENST00000313243_length(amino acids)=327AA_BP=309 MPSSSPSSFSSSTSSPSSSSSCAHRRQPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVG QSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRR DYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVP -------------------------------------------------------------- >90258_90258_8_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000379613_MAK_chr6_10764839_ENST00000474039_length(amino acids)=327AA_BP=309 MPSSSPSSFSSSTSSPSSSSSCAHRRQPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVG QSPYTSAPPLSHTPNADFQPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRR DYRRHEDLLHGPHALSSGLGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVP -------------------------------------------------------------- >90258_90258_9_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000482890_MAK_chr6_10764839_ENST00000313243_length(amino acids)=309AA_BP=291 MELSSNLFRPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADF QPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSG LGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAE -------------------------------------------------------------- >90258_90258_10_TFAP2A-MAK_TFAP2A_chr6_10404741_ENST00000482890_MAK_chr6_10764839_ENST00000474039_length(amino acids)=309AA_BP=291 MELSSNLFRPALCAHPESSSTWVRDREGHIRSRRSMKMLWKLTDNIKYEDCEDRHDGTSNGTARLPQLGTVGQSPYTSAPPLSHTPNADF QPPYFPPPYQPIYPQSQDPYSHVNDPYSLNPLHAQPQPQHPGWPGQRQSQESGLLHTHRGLPHQLSGLDPRRDYRRHEDLLHGPHALSSG LGDLSIHSLPHAIEEVPHVEDPGINIPDQTVIKKGPVSLSKSNSNAVSAIPINKDNLFGGVVNPNEVFCSVPGRLSLLSSTSKYKVTVAE -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr6:10404741/chr6:10764839) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | MAK |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000319516 | - | 4 | 7 | 29_117 | 250.66666666666666 | 434.0 | Compositional bias | Note=Gln/Pro-rich (transactivation domain) |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379604 | - | 4 | 7 | 29_117 | 254.66666666666666 | 438.0 | Compositional bias | Note=Gln/Pro-rich (transactivation domain) |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379608 | - | 4 | 7 | 29_117 | 248.66666666666666 | 432.0 | Compositional bias | Note=Gln/Pro-rich (transactivation domain) |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000482890 | - | 5 | 8 | 29_117 | 254.66666666666666 | 438.0 | Compositional bias | Note=Gln/Pro-rich (transactivation domain) |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000319516 | - | 4 | 7 | 57_62 | 250.66666666666666 | 434.0 | Motif | Note=PPxY motif |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379604 | - | 4 | 7 | 57_62 | 254.66666666666666 | 438.0 | Motif | Note=PPxY motif |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379608 | - | 4 | 7 | 57_62 | 248.66666666666666 | 432.0 | Motif | Note=PPxY motif |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000482890 | - | 5 | 8 | 57_62 | 254.66666666666666 | 438.0 | Motif | Note=PPxY motif |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000319516 | - | 4 | 7 | 280_410 | 250.66666666666666 | 434.0 | Region | Note=H-S-H (helix-span-helix)%2C dimerization |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379604 | - | 4 | 7 | 280_410 | 254.66666666666666 | 438.0 | Region | Note=H-S-H (helix-span-helix)%2C dimerization |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000379608 | - | 4 | 7 | 280_410 | 248.66666666666666 | 432.0 | Region | Note=H-S-H (helix-span-helix)%2C dimerization |
Hgene | TFAP2A | chr6:10404741 | chr6:10764839 | ENST00000482890 | - | 5 | 8 | 280_410 | 254.66666666666666 | 438.0 | Region | Note=H-S-H (helix-span-helix)%2C dimerization |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000313243 | 12 | 14 | 309_368 | 572.3333333333334 | 624.0 | Compositional bias | Note=Glu/Pro-rich | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000354489 | 11 | 13 | 309_368 | 572.3333333333334 | 624.0 | Compositional bias | Note=Glu/Pro-rich | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000474039 | 12 | 14 | 309_368 | 572.3333333333334 | 624.0 | Compositional bias | Note=Glu/Pro-rich | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000313243 | 12 | 14 | 4_284 | 572.3333333333334 | 624.0 | Domain | Protein kinase | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000354489 | 11 | 13 | 4_284 | 572.3333333333334 | 624.0 | Domain | Protein kinase | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000474039 | 12 | 14 | 4_284 | 572.3333333333334 | 624.0 | Domain | Protein kinase | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000313243 | 12 | 14 | 10_18 | 572.3333333333334 | 624.0 | Nucleotide binding | ATP | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000354489 | 11 | 13 | 10_18 | 572.3333333333334 | 624.0 | Nucleotide binding | ATP | |
Tgene | MAK | chr6:10404741 | chr6:10764839 | ENST00000474039 | 12 | 14 | 10_18 | 572.3333333333334 | 624.0 | Nucleotide binding | ATP |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
TFAP2A | |
MAK |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to TFAP2A-MAK |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to TFAP2A-MAK |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |